Christine Michel Lentz

Christine Lentz focuses her practice on FDA regulatory compliance, counselling clients that develop and commercialize FDA-regulated products, including drugs, biologics, medical devices, food and beverage, cosmetics, and dietary supplements. She also has experience navigating complex requirements at the intersection of FDA law, including issues that impact products and services regulated by FTC, DEA, CMS, USDA, TTB, CPSC, and state licensing authorities.

Christine supports companies in managing multi-faceted regulatory issues across the product life cycle, from development to product launch and post market compliance, to defending government enforcement actions. In particular, she advises clients on state and federal licensing and registration, labelling requirements, advertising and promotion, as well as commercial agreements. Christine also leverages her regulatory experience as a subject matter specialist on transactions, conducting due diligence on behalf of clients.

Prior to practicing law, Christine worked in preclinical research, supporting commercial contracts and business process management for a contract research organization (CRO). She leverages her prior experience to support clients on cross-cutting life science industry issues, including digital health regulation, litigation support and multi-jurisdictional assessments. She has conducted multi-jurisdictional surveys on issues including telehealth licensing, corporate practice of dentistry, medical device distribution, state-law laboratory billing, and corporate practice of medicine.